A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : APP / antipsychotic polypharmacy

[Related PubMed/MEDLINE]
Total Number of Papers: 36
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   APP  (>> Co-occurring Abbreviation)
Long Form:   antipsychotic polypharmacy
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Evaluation of Risk Factors for Antipsychotic Polypharmacy in Inpatient Psychiatry Units of a Community Hospital: A Retrospective Analysis. ---
2018 Antipsychotic polypharmacy prescribing and risk of hospital readmission. SLaM, SMI
2018 Characteristics of Medicaid Recipients Receiving Persistent Antipsychotic Polypharmacy. ---
2018 Correlates and predictors of antipsychotic drug polypharmacy in real-life settings: Results from a nationwide cohort study. ---
2018 Prevalence and correlates of antipsychotic polypharmacy in Hong Kong. ---
2017 Attitudes towards and rationale for antipsychotic polypharmacy among psychiatrists in Nigeria: Characteristics associated with high reported antipsychotic polypharmacy. FGA
2017 Prevalence and correlates of antipsychotic polypharmacy among outpatients with schizophrenia attending a tertiary psychiatric facility in Nigeria. GAF, LUNSERS, PANSS
2017 Prevalence of and factors associated with antipsychotic polypharmacy in patients with serious mental illness: Findings from a cross-sectional study in an upper-middle-income country. ---
2016 Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders. CGI-S, CI, CRIS, OR, SLaM
10  2016 Antipsychotic polypharmacy and quality of life in patients with schizophrenia treated in primary care in China. FGA, QOL, SGA
11  2016 Effectiveness of long-acting antipsychotics in clinical practice: 2. Effects of antipsychotic polypharmacy on risperidone long-acting injection and zuclopenthixol decanoate. CGI, LAIs, RLAI
12  2016 Predictors of long-term (≥6months) antipsychotic polypharmacy prescribing in secondary mental healthcare. SLaM, SMI
13  2016 Switching from 2 antipsychotics to 1 antipsychotic in schizophrenia: a randomized, double-blind, placebo-controlled study. APM, BPRS, CGI
14  2015 Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital. FGA, SGA
15  2015 Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China. QOL
16  2015 Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process. EHRs, SMI
17  2015 Frequency and correlates of antipsychotic polypharmacy among patients with schizophrenia in Denmark: A nation-wide pharmacoepidemiological study. CI
18  2014 Antipsychotic polypharmacy among a nationwide sample of community-dwelling persons with Alzheimer's disease. AD, BPSD
19  2014 Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment. ADHD, SGAs
20  2014 Prevalence and nature of antipsychotic polypharmacy among inpatients with schizophrenia spectrum disorders at an Australian mental health service. ---
21  2014 The prevalence of antipsychotic polypharmacy in schizophrenic patients discharged from psychiatric units in Poland. AP, FGA, SGA
22  2013 Antipsychotic polypharmacy in a treatment-refractory schizophrenia population receiving adjunctive treatment with electroconvulsive therapy. ECT, FGA, SGA
23  2013 Antipsychotic polypharmacy in psychotic disorders: a critical review of neurobiology, efficacy, tolerability and cost effectiveness. ---
24  2013 Antipsychotic polypharmacy: a Japanese survey of prescribers' attitudes and rationales. OR
25  2013 Antipsychotics: to combine or not to combine? ---
26  2012 Antipsychotic polypharmacy in inpatients with schizophrenia in Asia (2001-2009). ---
27  2012 Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice. ---
28  2012 Antipsychotic polypharmacy: a needle in a haystack? CPZeqs
29  2012 Common use of antipsychotic polypharmacy in older Asian patients with schizophrenia (2001-2009). ---
30  2012 Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009. FGAs, IQR
31  2012 Safety and tolerability of antipsychotic polypharmacy. ---
32  2011 Antipsychotic polypharmacy: a survey study of prescriber attitudes, knowledge and behavior. ---
33  2011 Reducing antipsychotic polypharmacy among psychogeriatric and adult patients with chronic schizophrenia. CPIP
34  2008 Clinical and social correlates with the use of depot antipsychotic drugs in outpatients with schizophrenia in China. BJ, DA, HK
35  2007 Clinical and social determinants of psychotropic drug prescription for schizophrenia outpatients in China. BJ, DA, HK
36  2005 Antipsychotic polypharmacy or monotherapy? SGA